JEFFERIES FINANCIAL GROUP IN (JEF)

US47233W1099 - Common Stock

76.22  +0.96 (+1.28%)

After market: 76.22 0 (0%)

Fundamental Rating

4

Taking everything into account, JEF scores 4 out of 10 in our fundamental rating. JEF was compared to 220 industry peers in the Capital Markets industry. JEF has a bad profitability rating. Also its financial health evaluation is rather negative. JEF is not overvalued while it is showing excellent growth. This is an interesting combination.



2

1. Profitability

1.1 Basic Checks

JEF had positive earnings in the past year.
In the past year JEF has reported a negative cash flow from operations.
Each year in the past 5 years JEF has been profitable.
The reported operating cash flow has been mixed in the past 5 years: JEF reported negative operating cash flow in multiple years.

1.2 Ratios

JEF has a worse Return On Assets (1.07%) than 67.28% of its industry peers.
JEF has a Return On Equity (6.74%) which is comparable to the rest of the industry.
JEF has a worse Return On Invested Capital (1.46%) than 73.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JEF is below the industry average of 7.00%.
Industry RankSector Rank
ROA 1.07%
ROE 6.74%
ROIC 1.46%
ROA(3y)1.57%
ROA(5y)1.62%
ROE(3y)8.65%
ROE(5y)8.81%
ROIC(3y)2.1%
ROIC(5y)1.72%

1.3 Margins

The Profit Margin of JEF (5.56%) is worse than 69.12% of its industry peers.
In the last couple of years the Profit Margin of JEF has remained more or less at the same level.
JEF's Operating Margin of 8.27% is on the low side compared to the rest of the industry. JEF is outperformed by 72.81% of its industry peers.
In the last couple of years the Operating Margin of JEF has declined.
JEF's Gross Margin of 60.05% is fine compared to the rest of the industry. JEF outperforms 60.83% of its industry peers.
JEF's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.27%
PM (TTM) 5.56%
GM 60.05%
OM growth 3Y-32.26%
OM growth 5Y-15.07%
PM growth 3Y-31.86%
PM growth 5Y0.3%
GM growth 3Y-9.21%
GM growth 5Y-4.77%

1

2. Health

2.1 Basic Checks

JEF has less shares outstanding than it did 1 year ago.
The number of shares outstanding for JEF has been reduced compared to 5 years ago.
The debt/assets ratio for JEF is higher compared to a year ago.

2.2 Solvency

JEF has an Altman-Z score of 0.43. This is a bad value and indicates that JEF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of JEF (0.43) is worse than 70.05% of its industry peers.
JEF has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of JEF (2.87) is worse than 81.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Altman-Z 0.43
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

JEF has a Current Ratio of 0.66. This is a bad value and indicates that JEF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.66, JEF is not doing good in the industry: 68.20% of the companies in the same industry are doing better.
JEF has a Quick Ratio of 0.66. This is a bad value and indicates that JEF is not financially healthy enough and could expect problems in meeting its short term obligations.
JEF has a worse Quick ratio (0.66) than 68.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

9

3. Growth

3.1 Past

JEF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.20%, which is quite impressive.
JEF shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.63% yearly.
The Revenue has grown by 67.34% in the past year. This is a very strong growth!
JEF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.01% yearly.
EPS 1Y (TTM)47.2%
EPS 3Y-21.12%
EPS 5Y19.63%
EPS Q2Q%240.91%
Revenue 1Y (TTM)67.34%
Revenue growth 3Y2.54%
Revenue growth 5Y9.01%
Sales Q2Q%42.42%

3.2 Future

JEF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.48% yearly.
JEF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.06% yearly.
EPS Next Y127.06%
EPS Next 2Y87.31%
EPS Next 3Y65.48%
EPS Next 5YN/A
Revenue Next Year46.05%
Revenue Next 2Y31.02%
Revenue Next 3Y24.06%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.16, the valuation of JEF can be described as expensive.
JEF's Price/Earnings ratio is a bit more expensive when compared to the industry. JEF is more expensive than 72.35% of the companies in the same industry.
When comparing the Price/Earnings ratio of JEF to the average of the S&P500 Index (27.20), we can say JEF is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 16.33, the valuation of JEF can be described as correct.
JEF's Price/Forward Earnings ratio is in line with the industry average.
JEF is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.16
Fwd PE 16.33

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JEF is valued a bit cheaper than 72.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.76

4.3 Compensation for Growth

JEF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JEF's earnings are expected to grow with 65.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)1.64
EPS Next 2Y87.31%
EPS Next 3Y65.48%

5

5. Dividend

5.1 Amount

JEF has a Yearly Dividend Yield of 1.86%. Purely for dividend investing, there may be better candidates out there.
JEF's Dividend Yield is slightly below the industry average, which is at 9.57.
JEF's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.86%

5.2 History

On average, the dividend of JEF grows each year by 22.79%, which is quite nice.
JEF has been paying a dividend for at least 10 years, so it has a reliable track record.
JEF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)22.79%
Div Incr Years1
Div Non Decr Years4

5.3 Sustainability

43.05% of the earnings are spent on dividend by JEF. This is a bit on the high side, but may be sustainable.
JEF's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.05%
EPS Next 2Y87.31%
EPS Next 3Y65.48%

JEFFERIES FINANCIAL GROUP IN

NYSE:JEF (12/20/2024, 8:19:54 PM)

After market: 76.22 0 (0%)

76.22

+0.96 (+1.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-25 2024-09-25/amc
Earnings (Next)01-06 2025-01-06/amc
Inst Owners68.79%
Inst Owner Change0.87%
Ins Owners21.56%
Ins Owner Change-4.03%
Market Cap15.66B
Analysts80
Price Target75.99 (-0.3%)
Short Float %7.29%
Short Ratio8.2
Dividend
Industry RankSector Rank
Dividend Yield 1.86%
Dividend Growth(5Y)22.79%
DP43.05%
Div Incr Years1
Div Non Decr Years4
Ex-Date11-18 2024-11-18 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.07%
Min EPS beat(2)-4.18%
Max EPS beat(2)0.05%
EPS beat(4)1
Avg EPS beat(4)-7.35%
Min EPS beat(4)-16.37%
Max EPS beat(4)0.05%
EPS beat(8)3
Avg EPS beat(8)-4.94%
EPS beat(12)5
Avg EPS beat(12)2.12%
EPS beat(16)9
Avg EPS beat(16)19.32%
Revenue beat(2)1
Avg Revenue beat(2)0.24%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)2.95%
Revenue beat(4)2
Avg Revenue beat(4)2.47%
Min Revenue beat(4)-4.15%
Max Revenue beat(4)13.53%
Revenue beat(8)4
Avg Revenue beat(8)13.06%
Revenue beat(12)8
Avg Revenue beat(12)16.27%
Revenue beat(16)12
Avg Revenue beat(16)22.49%
PT rev (1m)7.19%
PT rev (3m)21.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.39%
EPS NY rev (1m)2.4%
EPS NY rev (3m)4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 32.16
Fwd PE 16.33
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 1.56
P/tB 1.96
EV/EBITDA 16.76
EPS(TTM)2.37
EY3.11%
EPS(NY)4.67
Fwd EY6.12%
FCF(TTM)-10.33
FCFYN/A
OCF(TTM)-9.84
OCFYN/A
SpS59.29
BVpS48.89
TBVpS38.8
PEG (NY)0.25
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 1.07%
ROE 6.74%
ROCE 2.72%
ROIC 1.46%
ROICexc 1.84%
ROICexgc 2.12%
OM 8.27%
PM (TTM) 5.56%
GM 60.05%
FCFM N/A
ROA(3y)1.57%
ROA(5y)1.62%
ROE(3y)8.65%
ROE(5y)8.81%
ROIC(3y)2.1%
ROIC(5y)1.72%
ROICexc(3y)2.71%
ROICexc(5y)2.22%
ROICexgc(3y)3.13%
ROICexgc(5y)2.55%
ROCE(3y)3.68%
ROCE(5y)3.44%
ROICexcg growth 3Y-34.17%
ROICexcg growth 5Y-9.38%
ROICexc growth 3Y-34.01%
ROICexc growth 5Y-9.35%
OM growth 3Y-32.26%
OM growth 5Y-15.07%
PM growth 3Y-31.86%
PM growth 5Y0.3%
GM growth 3Y-9.21%
GM growth 5Y-4.77%
F-Score5
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Debt/EBITDA 24.45
Cap/Depr 59.71%
Cap/Sales 0.83%
Interest Coverage 0.31
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 0.43
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)76.34%
Cap/Depr(5y)103.26%
Cap/Sales(3y)1.66%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.2%
EPS 3Y-21.12%
EPS 5Y19.63%
EPS Q2Q%240.91%
EPS Next Y127.06%
EPS Next 2Y87.31%
EPS Next 3Y65.48%
EPS Next 5YN/A
Revenue 1Y (TTM)67.34%
Revenue growth 3Y2.54%
Revenue growth 5Y9.01%
Sales Q2Q%42.42%
Revenue Next Year46.05%
Revenue Next 2Y31.02%
Revenue Next 3Y24.06%
Revenue Next 5YN/A
EBIT growth 1Y94.26%
EBIT growth 3Y-30.54%
EBIT growth 5Y-7.42%
EBIT Next Year215.23%
EBIT Next 3Y70.56%
EBIT Next 5YN/A
FCF growth 1Y-177.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-168.9%
OCF growth 3YN/A
OCF growth 5YN/A